Literature DB >> 15177520

Glucocorticoid sensitivity of circulating monocytes in essential hypertension.

Petra H Wirtz1, Roland von Känel, Karl Frey, Ulrike Ehlert, Joachim E Fischer.   

Abstract

BACKGROUND: Essential hypertension ranks among the strongest cardiovascular risk factors. Cytokine production by monocytes plays a key role in atherosclerosis development and acute coronary syndromes. We investigated whether stimulated monocyte cytokine release and its inhibition by glucocorticoids would differ between hypertensive and normotensive subjects.
METHODS: Study participants were 222 middle-aged male employees with industrial jobs. Following the criteria of the World Health Organization/International Society for Hypertension, 76 subjects were classified as being hypertensive (systolic blood pressure > or = 140 mm Hg or diastolic blood pressure > or = 90 mm Hg). In vitro monocyte tumor necrosis factor (TNF)-alpha release after lipopolysaccharide (LPS) stimulation was assessed with and without coincubation with incremental doses of dexamethasone. Monocyte glucocorticoid sensitivity was defined as the dexamethasone concentration inhibiting TNF-alpha release by 50%.
RESULTS: Hypertensive subjects showed 11% higher LPS-stimulated TNF-alpha release than normotensive subjects (F(1,181)= 5.21, P =.024). In hypertensive subjects, monocyte glucocorticoid sensitivity was 21% lower than in normotensive subjects (F(1,178)= 4.94, P =.027), indicating that dexamethasone inhibited relatively less TNF-alpha release in hypertensive subjects. Results held significance when a set of classic cardiovascular risk factors was controlled for.
CONCLUSION: The findings suggest that proinflammatory activity of circulating monocytes is higher in hypertensive than in normotensive men, providing one potential pathway to explain the increased atherosclerotic risk with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177520     DOI: 10.1016/j.amjhyper.2004.01.010

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  8 in total

1.  Glucocorticoid receptor sensitivity in early pregnancy in an African American cohort.

Authors:  Lasha S Clarke; Elizabeth J Corwin; Anne L Dunlop; Allison Hankus; Joshua M Bradner; Sudeshna Paul; Yunshen Jiao; Alicia K Smith; Nikolay Patrushev; Jennifer G Mulle; Timothy D Read; Carol J R Hogue; Bradley D Pearce
Journal:  Am J Reprod Immunol       Date:  2020-05-23       Impact factor: 3.886

Review 2.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

3.  Role of the immune system in hypertension: modulation by dietary antioxidants.

Authors:  Sudesh Vasdev; Jennifer Stuckless; Vernon Richardson
Journal:  Int J Angiol       Date:  2011-12

4.  Human monocyte transcriptional profiling identifies IL-18 receptor accessory protein and lactoferrin as novel immune targets in hypertension.

Authors:  Matthew R Alexander; Allison E Norlander; Fernando Elijovich; Ravi V Atreya; Amadou Gaye; Juan S Gnecco; Cheryl L Laffer; Cristi L Galindo; Meena S Madhur
Journal:  Br J Pharmacol       Date:  2018-06-21       Impact factor: 8.739

5.  Neighborhood Characteristics and Cardiovascular Biomarkers in Middle-Aged and Older Adults: the Baltimore Memory Study.

Authors:  Laken C Roberts; Brian S Schwartz; Laura J Samuel
Journal:  J Urban Health       Date:  2021-02       Impact factor: 3.671

6.  Acute stress reduces wound-induced activation of microbicidal potential of ex vivo isolated human monocyte-derived macrophages.

Authors:  Ulrike Kuebler; Petra H Wirtz; Miho Sakai; Andreas Stemmer; Ulrike Ehlert
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

Review 7.  O-Linked β-N-Acetylglucosamine Modification: Linking Hypertension and the Immune System.

Authors:  Rinaldo Rodrigues Dos Passos Junior; Gisele Facholi Bomfim; Fernanda R Giachini; Rita C Tostes; Victor Vitorino Lima
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

8.  High Monocyte Count Associated with Human Cytomegalovirus Replication In Vivo and Glucocorticoid Therapy May Be a Hallmark of Disease.

Authors:  Przemyslaw Zdziarski; Andrzej Gamian
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.